doi: 10.1038/s41580-019-0173-8 105 SahooGSamalDKhandayatarayPMurthyMK
Do Not Alter: Never split, crush, or chew the tablet
Patients with certain genetic variants may respond more strongly to semaglutide monotherapy, while others benefit from dual-pathway activation using tirzepatide or GLP-Squared combinations
GLP-1 Receptor Shared with Semaglutide and Tirzepatide GLP-1 receptor activation is associated with appetite regulation, delayed gastric emptying, and glucose-dependent insulin secretion
Some specialized therapies, such as high-dose vitamin C or NAD+, may run longer to reduce side effects
If new health concerns arise or if pre-existing conditions worsen, it might be prudent to stop taking the medication under a doctors guidance